Australia In Vivo Cro Market Size & Outlook, 2024-2030

The in vivo cro market in Australia is expected to reach a projected revenue of US$ 53.5 million by 2030. A compound annual growth rate of 8.5% is expected of Australia in vivo cro market from 2025 to 2030.
Revenue, 2024 (US$M)
$32.8
Forecast, 2030 (US$M)
$53.5
CAGR, 2025 - 2030
8.5%
Report Coverage
Australia

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Australia in vivo cro market, 2018-2030 (US$M)

Australia in vivo cro market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Australia in vivo cro market highlights

  • The Australia in vivo cro market generated a revenue of USD 30.3 million in 2023 and is expected to reach USD 53.5 million by 2030.
  • The Australia market is expected to grow at a CAGR of 8.5% from 2024 to 2030.
  • In terms of segment, small molecule was the largest revenue generating modality type in 2023.
  • Large Molecule is the most lucrative modality type segment registering the fastest growth during the forecast period.


In vivo cro market data book summary

Market revenue in 2023USD 30.3 million
Market revenue in 2030USD 53.5 million
Growth rate8.5% (CAGR from 2023 to 2030)
Largest segmentSmall molecule
Fastest growing segmentLarge Molecule
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSmall Molecule, Large Molecule
Key market players worldwideIQVIA Holdings Inc, JSR Corp, Taconic Biosciences, Evotec SE, Janvier Labs, Charles River Laboratories International Inc, Icon PLC, Labcorp Holdings Inc, PAREXEL, GemPharmatech, PsychoGenics, Biocytogen, SMO-Group


Other key industry trends

  • In terms of revenue, Australia accounted for 0.7% of the global in vivo cro market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan in vivo cro market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 122.7 million by 2030.

Small molecule was the largest segment with a revenue share of 63.7% in 2024. Horizon Databook has segmented the Australia in vivo cro market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.


The Department of Health and industry stakeholders are collaborating to improve Australia’s clinical research and trial environment. The initiatives include receiving funding support from the Medical Research Future Fund to develop drug discovery centers, benefitting from favorable R&D tax incentives, and implementing streamlined regulatory pathways. These factors are expected to drive Australia’s in vivo CRO market during the forecast period.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

In Vivo CRO Market Companies

Name Profile # Employees HQ Website
SMO-Group View profile 101-250 Kiev, Kyyivs'ka Oblast', Ukraine, Europe https://www.smo-group.com/
Biocytogen View profile 1001-5000 Daxing, Beijing, China, Asia https://biocytogen.com
PsychoGenics View profile 101-250 Paramus, New Jersey, United States, North America http://psychogenics.com
GemPharmatech View profile 1001-5000 Nanjing, Jiangsu, China, Asia http://www.gempharmatech.com/
Janvier Labs View profile 251-500 Le Genest, Pays de la Loire, France, Europe https://janvier-labs.com
Taconic Biosciences View profile 501-1000 Hudson, New York, United States, North America http://www.taconic.com
JSR Corp View profile 7994 1-9-2 Higashi-Shimbashi, Shiodome Sumitomo Building, 22nd Floor, Minato-ku, Tokyo, Japan, 105-8640 http://www.jsr.co.jp
Evotec SE View profile 5055 Essener Bogen 7, Manfred Eigen Campus, Hamburg, Germany, 22419 https://www.evotec.com
PAREXEL View profile 10001+ Waltham, Massachusetts, United States, North America http://www.parexel.com
IQVIA Holdings Inc View profile 87000 2400 Ellis Road, Durham, NC, United States, 27703 https://www.iqvia.com
Icon PLC View profile 41150 South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 https://www.iconplc.com
Labcorp Holdings Inc View profile 67000 358 South Main Street, Burlington, NC, United States, 27215 https://www.labcorp.com
Charles River Laboratories International Inc View profile 21400 251 Ballardvale Street, Wilmington, MA, United States, 01887 https://www.criver.com

Australia in vivo cro market size, by modality type, 2018-2030 (US$M)

Australia In Vivo CRO Market Outlook Share, 2024 & 2030 (US$M)

Australia in vivo cro market size, by modality type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online